{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:09:31Z","timestamp":1783548571872,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Chulalongkorn University, and Immunothai, Limited","award":["GRU-58-010-30-001"],"award-info":[{"award-number":["GRU-58-010-30-001"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jns.2016.05.056","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T16:32:26Z","timestamp":1464712346000},"page":"162-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Biochemical and clinical effects of Whey protein supplementation in Parkinson's disease: A pilot study"],"prefix":"10.1016","volume":"367","author":[{"given":"Piyaratana","family":"Tosukhowong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanchai","family":"Boonla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thasinas","family":"Dissayabutra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalita","family":"Kaewwilai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasipa","family":"Muensri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanisa","family":"Chotipanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juho","family":"Joutsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Rinne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6901-2064","authenticated-orcid":false,"given":"Roongroj","family":"Bhidayasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2016.05.056_bb0005","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson's disease. First of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2016.05.056_bb0010","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/brain\/awl332","article-title":"The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea","volume":"130","author":"Huot","year":"2007","journal-title":"Brain"},{"issue":"Suppl. 3","key":"10.1016\/j.jns.2016.05.056_bb0015","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson's disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2016.05.056_bb0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.freeradbiomed.2013.05.001","article-title":"Glutathione metabolism and Parkinson's disease","volume":"62","author":"Smeyne","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jns.2016.05.056_bb0025","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/BF01291884","article-title":"Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease","volume":"104","author":"Pearce","year":"1997","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jns.2016.05.056_bb0030","first-page":"1362","article-title":"Redox imbalance in Parkinson's disease","volume":"2008","author":"Chinta","year":"1780","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jns.2016.05.056_bb0035","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1096\/fj.08-125443","article-title":"Glutathione\u2013a review on its role and significance in Parkinson's disease","volume":"23","author":"Martin","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.jns.2016.05.056_bb0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/MCO.0000000000000134","article-title":"Glutathione redox imbalance in brain disorders","volume":"18","author":"Gu","year":"2015","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.jns.2016.05.056_bb0045","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/mds.22401","article-title":"Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease","volume":"24","author":"Hauser","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.05.056_bb0050","first-page":"136","article-title":"Therapeutic applications of Whey protein","volume":"9","author":"Marshall","year":"2004","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.jns.2016.05.056_bb0055","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/0748233709104870","article-title":"Whey proteins influence hepatic glutathione after CCl4 intoxication","volume":"25","author":"Balbis","year":"2009","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.jns.2016.05.056_bb0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1476-511X-10-57","article-title":"Protective effect of Whey proteins against nonalcoholic fatty liver in rats","volume":"10","author":"Hamad","year":"2011","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.jns.2016.05.056_bb0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2362.2001.00781.x","article-title":"Oral supplementation with Whey proteins increases plasma glutathione levels of HIV-infected patients","volume":"31","author":"Micke","year":"2001","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.jns.2016.05.056_bb0070","first-page":"296","article-title":"The biological activity of undenatured dietary Whey proteins: role of glutathione","volume":"14","author":"Bounous","year":"1991","journal-title":"Clin. Invest. Med."},{"key":"10.1016\/j.jns.2016.05.056_bb0075","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1440-1746.2009.05865.x","article-title":"Open-labeled pilot study of cysteine-rich Whey protein isolate supplementation for nonalcoholic steatohepatitis patients","volume":"24","author":"Chitapanarux","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jns.2016.05.056_bb0080","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/mds.10473","article-title":"The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations","volume":"18","author":"Movement Disorder Society Task Force on Rating Scales for Parkinson's D","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.05.056_bb0085","first-page":"964","article-title":"Nitric oxide and peroxynitrite serum levels in Parkinson's disease: correlation of oxidative stress and the severity of the disease","volume":"17","author":"Kouti","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jns.2016.05.056_bb0090","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.nucmedbio.2011.02.016","article-title":"Evaluation of striatal oxidative stress in patients with Parkinson's disease using [62Cu]ATSM PET","volume":"38","author":"Ikawa","year":"2011","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.jns.2016.05.056_bb0095","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/ane.12106","article-title":"Elevated homocysteine levels in levodopa-treated idiopathic Parkinson's disease: a meta-analysis","volume":"128","author":"Hu","year":"2013","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2016.05.056_bb0100","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/mds.22511","article-title":"Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia","volume":"24","author":"Zoccolella","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.05.056_bb0105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/157488912803252014","article-title":"Immunocal(R) and preservation of glutathione as a novel neuroprotective strategy for degenerative disorders of the nervous system","volume":"7","author":"Ross","year":"2012","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"10.1016\/j.jns.2016.05.056_bb0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neulet.2008.10.045","article-title":"Preventive effects of genistein on motor dysfunction following 6-hydroxydopamine injection in ovariectomized rats","volume":"448","author":"Kyuhou","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jns.2016.05.056_bb0115","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1152\/jappl.1999.87.4.1381","article-title":"Effect of supplementation with a cysteine donor on muscular performance","volume":"87","author":"Lands","year":"1999","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.jns.2016.05.056_bb0120","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.05.056_bb0125","series-title":"Clinical Global Impression. ECDEU Assessment Manual for Psychopharmacology-revised","author":"Guy","year":"1976"},{"key":"10.1016\/j.jns.2016.05.056_bb0130","series-title":"The Parkinson's Disease Questionnaire","author":"Jenkinson","year":"2012"},{"key":"10.1016\/j.jns.2016.05.056_bb0135","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.neuroimage.2012.03.020","article-title":"Age-specific CT and MRI templates for spatial normalization","volume":"61","author":"Rorden","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.jns.2016.05.056_bb0140","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/jcbfm.1985.87","article-title":"Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations","volume":"5","author":"Patlak","year":"1985","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jns.2016.05.056_bb0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0304-3835(91)90200-2","article-title":"Whey proteins in cancer prevention","volume":"57","author":"Bounous","year":"1991","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jns.2016.05.056_bb0150","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/09637480701253581","article-title":"An open-label dose-response study of lymphocyte glutathione levels in healthy men and women receiving pressurized Whey protein isolate supplements","volume":"58","author":"Zavorsky","year":"2007","journal-title":"Int. J. Food Sci. Nutr."},{"key":"10.1016\/j.jns.2016.05.056_bb0155","doi-asserted-by":"crossref","first-page":"333S","DOI":"10.1093\/jn\/136.1.333S","article-title":"Symposium on branched-chain amino acids: conference summary","volume":"136","author":"Cynober","year":"2006","journal-title":"J. Nutr."},{"key":"10.1016\/j.jns.2016.05.056_bb0160","doi-asserted-by":"crossref","first-page":"533S","DOI":"10.1093\/jn\/136.2.533S","article-title":"Leucine regulates translation initiation of protein synthesis in skeletal muscle after exercise","volume":"136","author":"Norton","year":"2006","journal-title":"J. Nutr."},{"key":"10.1016\/j.jns.2016.05.056_bb0165","doi-asserted-by":"crossref","first-page":"464","DOI":"10.18632\/aging.100322","article-title":"Branched-chain amino acids, mitochondrial biogenesis, and healthspan: an evolutionary perspective","volume":"3","author":"Valerio","year":"2011","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jns.2016.05.056_bb0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0955-2863(98)00087-4","article-title":"Nonessential amino acids are not necessary to stimulate net muscle protein synthesis in healthy volunteers","volume":"10","author":"Tipton","year":"1999","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.jns.2016.05.056_bb0175","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3945\/jn.113.174375","article-title":"Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials","volume":"143","author":"Gluud","year":"2013","journal-title":"J. Nutr."},{"key":"10.1016\/j.jns.2016.05.056_bb0180","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/hep.24412","article-title":"Branched-chain amino acids as pharmacological nutrients in chronic liver disease","volume":"54","author":"Kawaguchi","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jns.2016.05.056_bb0185","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3892\/etm.2013.1329","article-title":"Effect of Whey protein on plasma amino acids in diabetic mice","volume":"6","author":"Han","year":"2013","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.jns.2016.05.056_bb0190","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1152\/japplphysiol.00076.2009","article-title":"Ingestion of Whey hydrolysate, casein, or soy protein isolate: effects on mixed muscle protein synthesis at rest and following resistance exercise in young men","volume":"107","author":"Tang","year":"2009","journal-title":"J. Appl. Physiol. (1985)"},{"key":"10.1016\/j.jns.2016.05.056_bb0195","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3945\/ajcn.110.008102","article-title":"Whey protein stimulates postprandial muscle protein accretion more effectively than do casein and casein hydrolysate in older men","volume":"93","author":"Pennings","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.jns.2016.05.056_bb0200","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.clnu.2011.05.008","article-title":"Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical food","volume":"30","author":"Deutz","year":"2011","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.jns.2016.05.056_bb0205","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/mds.22705","article-title":"Major nutritional issues in the management of Parkinson's disease","volume":"24","author":"Barichella","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.05.056_bb0210","article-title":"Malnutrition in a sample of community-dwelling people with Parkinson's disease","volume":"8","author":"Sheard","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2016.05.056_bb0215","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1753-4887.2011.00413.x","article-title":"Prevalence of malnutrition in Parkinson's disease: a systematic review","volume":"69","author":"Sheard","year":"2011","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.jns.2016.05.056_bb0220","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/PHM.0b013e3181a9ed9b","article-title":"Is there muscular weakness in Parkinson's disease?","volume":"89","author":"Cano-de-la-Cuerda","year":"2010","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"10.1016\/j.jns.2016.05.056_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mds.21690","article-title":"Parkinson's disease and resistive exercise: rationale, review, and recommendations","volume":"23","author":"Falvo","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.05.056_bb0230","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/mds.22227","article-title":"Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients","volume":"24","author":"Camicioli","year":"2009","journal-title":"Mov. Disord."},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2016.05.056_bb0235","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1038\/sj.cdd.4401451","article-title":"Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease","volume":"11","author":"Austin","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jns.2016.05.056_bb0240","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/mds.20261","article-title":"Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients","volume":"20","author":"Lamberti","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.05.056_bb0245","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fnagi.2014.00036","article-title":"The emerging role of nutrition in Parkinson's disease","volume":"6","author":"Seidl","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jns.2016.05.056_bb0250","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1134\/S1819712411020073","article-title":"Peripheral markers for oxidative stress in Parkinson's disease patients of Eastern India","volume":"5","author":"Sanyal","year":"2011","journal-title":"Neurochem. J."},{"key":"10.1016\/j.jns.2016.05.056_bb0255","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-2236(03)00032-8","article-title":"Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders","volume":"26","author":"Mattson","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jns.2016.05.056_bb0260","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3988\/jcn.2014.10.4.281","article-title":"Hyperhomocysteinemia and neurologic disorders: a review","volume":"10","author":"Ansari","year":"2014","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.jns.2016.05.056_bb0265","article-title":"The combination of homocysteine and C-reactive protein predicts the outcomes of Chinese patients with Parkinson's disease and vascular parkinsonism","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16303252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16303252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T22:45:15Z","timestamp":1567982715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X16303252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":53,"alternative-id":["S0022510X16303252"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2016.05.056","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biochemical and clinical effects of Whey protein supplementation in Parkinson's disease: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2016.05.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}